Cargando…

Therapeutic drug monitoring of imatinib

Detalles Bibliográficos
Autor principal:	Wallemacq, Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Hematologia e Hemoterapia 2011
Materias:	Scientific Comments
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415760/ https://www.ncbi.nlm.nih.gov/pubmed/23049314 http://dx.doi.org/10.5581/1516-8484.20110072

Ejemplares similares

Comment on: Determination of serum levels of imatinib mesylate in patients with chronic myeloid leukemia: validation and application of a new analytical method to monitor treatment compliance
por: Simpson, David C
Publicado: (2013)

Scientific comment on: “Analysis of imatinib adherence in chronic myeloid leukemia: a retrospective study in a referral hospital in the Brazilian Amazon”. Who likes to take medicine forever?()
por: Bendit, Israel
Publicado: (2019)

Imatinib in COVID-19: hope and caution
por: Bernal-Bello, David, et al.
Publicado: (2021)

CostPlus and implications for generic imatinib
por: Jenei, Kristina, et al.
Publicado: (2022)

BCR-ABL1 level monitoring in chronic myeloid leukemia by real time polymerase chain reaction in Brazil – not so real()
por: Pagnano, Katia Borgia Barbosa
Publicado: (2017)

Successful treatment of chronic myeloid leukemia with tyrosine kinase inhibitors goes beyond access to drugs
por: Conchon, Monika
Publicado: (2013)

Therapeutic drug monitoring for imatinib: Current status and Indian experience
por: Arora, Brijesh, et al.
Publicado: (2013)

Special features of quantification of CD8(+)CD38(+) T-cells by flow cytometry does not represent a good biomarker to monitor the reactivation of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation
por: Martins Filho, Olindo Assis
Publicado: (2011)

Can therapeutic drug monitoring increase the safety of Imatinib in GIST patients?
por: Zhuang, Wei, et al.
Publicado: (2018)

The Steps to Therapeutic Drug Monitoring: A Structured Approach Illustrated With Imatinib
por: Buclin, Thierry, et al.
Publicado: (2020)

Cost effectiveness of therapeutic drug monitoring for imatinib administration in chronic myeloid leukemia
por: Kim, Kibum, et al.
Publicado: (2019)

Effectiveness of confidential unit exclusion for screening blood donors
por: Eder, Anne
Publicado: (2011)

Comments on Brazilian workshop model for training investigators in chronic graft-versus-host disease according to the 2005-2006 National Institutes of Health recommendations
por: Lee, Stephanie
Publicado: (2011)

Comments on the evaluation of lymphocyte levels in a random sample of 218 elderly individuals from São Paulo city
por: Blomberg, Bonnie B., et al.
Publicado: (2011)

The Langerhans cell histiocytosis: a disease in search of an identity
por: Rodriguez-Galindo, Carlos
Publicado: (2011)

The role of hemovigilance as a mechanism to increase transfusion safety
por: Moraes-Souza, Hélio
Publicado: (2011)

Retention of blood donors: strategies to fulfill the requirements of blood centers
por: de Almeida Neto, Cesar
Publicado: (2011)

A brief explanation of the air traffic controller professional activity
por: Ferreira Filho, Bemildo Alvaro
Publicado: (2011)

Compliance and adherence of patients in the treatment of acute lymphoblastic leukemia
por: Barr, Ronald Duncan
Publicado: (2011)

Conditioning regimen using busulfan plus melphalan in hematopoietic stem cell transplantation: can this conditioning regimen be used in autologous or allogeneic transplantation for acute leukemia?
por: Lemoli, Roberto M., et al.
Publicado: (2011)

Oxidative status in sickle cell anemia
por: Magalhães, Silvia Maria Meira
Publicado: (2011)

The expression of the CD56 antigen is associated with poor prognosis in patients with acute myeloid leukemia
por: Rego, Eduardo Magalhães
Publicado: (2011)

Confidential donation confirmation as a alternative exclusion
por: Gonçalez, Thelma T
Publicado: (2011)

Perforin and hematological cancer
por: Covas, Dimas Tadeu
Publicado: (2011)

Titers of ABO antibodies in group O blood donors: patient safety and blood product supply remain a challenge
por: Denomme, Gregory
Publicado: (2011)

Progress in chronic graft-versus-host disease
por: Martin, Paul J
Publicado: (2011)

Clinical guidelines in Hematology
por: Bernardo, Wanderley Marques
Publicado: (2011)

The importance of cytogenetics in polycythemia vera, primary myelofibrosis and essential thrombocythemia
por: Conchon, Monika
Publicado: (2011)

On the relevance of outpatient intravenous iron therapy for anemia management
por: Muñoz, Manuel
Publicado: (2011)

Allergic rhinitis and association with the O blood group
por: Carpeggiani, Clara
Publicado: (2011)

Secondary myeloid neoplasias: an emerging group of diseases
por: Hernández-Rivas, Jesús M
Publicado: (2011)

Peripheral hematopoietic progenitor cell mobilization for autologous transplantation in hematologic malignancies
por: Marques Jr, José Francisco Comenalli
Publicado: (2011)

Hematopoietic stem cell transplantation for Hodgkin's disease
por: Patah, Poliana, et al.
Publicado: (2011)

Molecular polymorphisms of human blood groups: a universe to unravel
por: de Mattos, Luiz Carlos
Publicado: (2011)

Sickle cell disease: from the beginning until it was recognized as a public health disease
por: Naoum, Paulo Cesar
Publicado: (2011)

Anemia and infection: a complex relationship
por: Viana, Marcos Borato
Publicado: (2011)

Comprehensive healthcare for individuals with sickle cell disease - a constant challenge
por: Cançado, Rodolfo Delfini
Publicado: (2011)

Enrichment of iron and folic acid: the real need and the dangers of this initiative
por: Fisberg, Mauro, et al.
Publicado: (2011)

On the need for an international effort to capture, share and use crystallization screening data
por: Newman, Janet, et al.
Publicado: (2012)

Detection and analysis of unusual features in the structural model and structure-factor data of a birch pollen allergen
por: Rupp, Bernhard
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_l95f0smdpen7idf59bt6ua2g7p